Guillain-Barré syndrome in a patient on adalimumab for the treatment of psoriasis

The use of TNF-α inhibitors for the treatment of moderate to severe psoriasis and psoriatic arthritis is increasingly more frequent. The authors report a case of Guillain-Barré syndrome as a late manifestation of the treatment with adalimumab. Although unusual, this is relevant for professionals who...

Descripción completa

Detalles Bibliográficos
Autores principales: de Natividade, Natallia Barreiros, Felix, Paulo Antonio Oldani, Lerer, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Dermatologia 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5726687/
https://www.ncbi.nlm.nih.gov/pubmed/29267456
http://dx.doi.org/10.1590/abd1806-4841.20175871
_version_ 1783285742724710400
author de Natividade, Natallia Barreiros
Felix, Paulo Antonio Oldani
Lerer, Claudio
author_facet de Natividade, Natallia Barreiros
Felix, Paulo Antonio Oldani
Lerer, Claudio
author_sort de Natividade, Natallia Barreiros
collection PubMed
description The use of TNF-α inhibitors for the treatment of moderate to severe psoriasis and psoriatic arthritis is increasingly more frequent. The authors report a case of Guillain-Barré syndrome as a late manifestation of the treatment with adalimumab. Although unusual, this is relevant for professionals who prescribe biologic drugs. We also stress the importance of investigating the past and family medical history regarding demyelinating diseases before starting treatment.
format Online
Article
Text
id pubmed-5726687
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Sociedade Brasileira de Dermatologia
record_format MEDLINE/PubMed
spelling pubmed-57266872017-12-18 Guillain-Barré syndrome in a patient on adalimumab for the treatment of psoriasis de Natividade, Natallia Barreiros Felix, Paulo Antonio Oldani Lerer, Claudio An Bras Dermatol Case Report The use of TNF-α inhibitors for the treatment of moderate to severe psoriasis and psoriatic arthritis is increasingly more frequent. The authors report a case of Guillain-Barré syndrome as a late manifestation of the treatment with adalimumab. Although unusual, this is relevant for professionals who prescribe biologic drugs. We also stress the importance of investigating the past and family medical history regarding demyelinating diseases before starting treatment. Sociedade Brasileira de Dermatologia 2017 /pmc/articles/PMC5726687/ /pubmed/29267456 http://dx.doi.org/10.1590/abd1806-4841.20175871 Text en ©2017 by Anais Brasileiros de Dermatologia http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License which permits unrestricted non-commercial use, distribution, and reproduction in any medium provided the original work is properly cited.
spellingShingle Case Report
de Natividade, Natallia Barreiros
Felix, Paulo Antonio Oldani
Lerer, Claudio
Guillain-Barré syndrome in a patient on adalimumab for the treatment of psoriasis
title Guillain-Barré syndrome in a patient on adalimumab for the treatment of psoriasis
title_full Guillain-Barré syndrome in a patient on adalimumab for the treatment of psoriasis
title_fullStr Guillain-Barré syndrome in a patient on adalimumab for the treatment of psoriasis
title_full_unstemmed Guillain-Barré syndrome in a patient on adalimumab for the treatment of psoriasis
title_short Guillain-Barré syndrome in a patient on adalimumab for the treatment of psoriasis
title_sort guillain-barré syndrome in a patient on adalimumab for the treatment of psoriasis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5726687/
https://www.ncbi.nlm.nih.gov/pubmed/29267456
http://dx.doi.org/10.1590/abd1806-4841.20175871
work_keys_str_mv AT denatividadenatalliabarreiros guillainbarresyndromeinapatientonadalimumabforthetreatmentofpsoriasis
AT felixpauloantoniooldani guillainbarresyndromeinapatientonadalimumabforthetreatmentofpsoriasis
AT lererclaudio guillainbarresyndromeinapatientonadalimumabforthetreatmentofpsoriasis

Ejemplares similares